FDA Approves Two Hologic HPV Tests
FDA Approves Two Hologic HPV Tests
Hologic, Inc., (Hologic or the Company) (Nasdaq: HOLX), a leading women's healthcare company dedicated to serving the healthcare needs of women, announced that the U.S. Food and Drug Administration (FDA) has approved the Company's premarket approval (PMA) applications for both the Cervista(TM) HPV HR (high risk) and the Cervista HPV 16/18 tests.
What next?
Posting Komentar